Who were the pharma standouts in the social media world last week? According to a Pharmalot report, Astellas Pharma of Japan made a 1,100% jump in social media buzz from last week to the previous week after an FDA advisory panel gave the firm's overactive-bladder drug a nod. Pfizer ($PFE) was also in the social media spotlight, with a 544% increase because of its controversial association with the conservative American Legislative Executive Council. Social media data for Pharmalot's report were from Semantelli. Item